Robertson Stephens Wealth Management, LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 73 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
Robertson Stephens Wealth Management, LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$136,000
-55.7%
133,840
-39.9%
0.02%
-59.5%
Q2 2021$307,000
-14.7%
222,619
+4.9%
0.04%
-36.2%
Q1 2021$360,000
+37.4%
212,238
+0.1%
0.06%
+5.5%
Q4 2020$262,000
-13.0%
212,0520.0%0.06%
-25.7%
Q3 2020$301,000
+144.7%
212,052
+108.0%
0.07%
+111.4%
Q2 2020$123,000
-0.8%
101,965
-2.7%
0.04%
-16.7%
Q1 2020$124,000104,7950.04%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Monashee Investment Management LLC 1,652,190$3,817,0002.58%
LINCOLN CAPITAL CORP 62,000$143,0000.13%
Laurion Capital Management LP 1,944,727$4,492,0000.08%
Cedar Wealth Management, LLC 46,395$107,0000.08%
Fosun International Ltd 301,708$709,0000.04%
BCWM, LLC 35,100$811,0000.04%
Engineers Gate Manager LP 170,800$395,0000.03%
Alpine Global Management, LLC 45,211$104,0000.03%
MOORE CAPITAL MANAGEMENT, LP 250,000$578,0000.02%
SECTORAL ASSET MANAGEMENT INC 73,778$170,0000.02%
View complete list of ACELRX PHARMACEUTICALS INC shareholders